SW1353（骨肉瘤細(xì)胞）  
產(chǎn)品品牌：ATCC
價(jià)格：詢價(jià)
我公司擁有國(guó)內(nèi)的細(xì)胞服務(wù)技術(shù)、先進(jìn)的儀器設(shè)備和專業(yè)的ELISA檢測(cè)試劑盒， 生物素標(biāo)記、熒光素標(biāo)記、酶標(biāo)記等，廣泛用于多種分析研究與技術(shù)測(cè)定。

產(chǎn)品說(shuō)明：
The SW 1353 cell line was initiated by A. Leibovitz at the Scott and White Clinic, Temple, Texas in 1977 from a primary grade II chondrosarcoma of the right humerus obtained from a 72 year old female Caucasian.
The initial culture medium was L-15 containing cortisone and insulin plus 10% fetal bovine serum and antibiotics.
A frozen ampule at passage 12 was received at the ATCC in January, 1982.
相關(guān)產(chǎn)品：
SW1353（骨肉瘤細(xì)胞） 
ES-2（卵巢透明細(xì)胞癌細(xì)胞） 
Saos-2（成骨肉瘤細(xì)胞） 
MDA-MB-468（乳腺癌細(xì)胞） 
SK-MES-1（肺鱗癌細(xì)胞） 
MDA-MB-435S（乳腺癌細(xì)胞） 
NCI-H661（大細(xì)胞肺癌細(xì)胞）